CA2063576A1 - Vehicules a liberation lente servant a reduire au minimum l'irritation cutanee due a des compositions topiques - Google Patents

Vehicules a liberation lente servant a reduire au minimum l'irritation cutanee due a des compositions topiques

Info

Publication number
CA2063576A1
CA2063576A1 CA2063576A CA2063576A CA2063576A1 CA 2063576 A1 CA2063576 A1 CA 2063576A1 CA 2063576 A CA2063576 A CA 2063576A CA 2063576 A CA2063576 A CA 2063576A CA 2063576 A1 CA2063576 A1 CA 2063576A1
Authority
CA
Canada
Prior art keywords
vehicles
slow release
skin
active ingredient
topical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2063576A
Other languages
English (en)
Other versions
CA2063576C (fr
Inventor
Gail S. Bazzano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27001708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2063576(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2063576A1 publication Critical patent/CA2063576A1/fr
Application granted granted Critical
Publication of CA2063576C publication Critical patent/CA2063576C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002063576A 1989-06-07 1990-06-07 Vehicules a liberation lente servant a reduire au minimum l'irritation cutanee due a des compositions topiques Expired - Fee Related CA2063576C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36252989A 1989-06-07 1989-06-07
US362,529 1989-06-07
US42905189A 1989-10-30 1989-10-30
US429,051 1989-10-30

Publications (2)

Publication Number Publication Date
CA2063576A1 true CA2063576A1 (fr) 1990-12-08
CA2063576C CA2063576C (fr) 1994-01-25

Family

ID=27001708

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002063576A Expired - Fee Related CA2063576C (fr) 1989-06-07 1990-06-07 Vehicules a liberation lente servant a reduire au minimum l'irritation cutanee due a des compositions topiques

Country Status (5)

Country Link
US (2) US5721275A (fr)
EP (1) EP0481007B1 (fr)
CA (1) CA2063576C (fr)
DE (1) DE69029804T2 (fr)
WO (1) WO1990014833A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9021320D0 (en) * 1990-10-01 1990-11-14 Diomed Dev Ltd Compositions for topical application
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
EP0608433B1 (fr) * 1992-07-13 2004-05-19 Shiseido Company, Ltd. Composition de preparation dermatologique
US5690923A (en) * 1993-01-07 1997-11-25 Yamanouchi Europe B.V. Stable topical retinoid compositions
ZA954599B (en) * 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
AU5777498A (en) * 1997-01-13 1998-08-03 Cilag A.G. Liposome-based topical tretinoin formulation
US5968534A (en) * 1998-03-04 1999-10-19 Campbell; John Compound for the amelioration of pseudofollicultis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6641650B1 (en) * 2000-02-24 2003-11-04 Conard E. Kaiser Gelled printing ink compositions
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
CN102327253A (zh) * 2000-04-26 2012-01-25 沃特森药物公司 最小化与奥昔布宁疗法有关的副作用
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6353029B1 (en) * 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
FR2823669B1 (fr) * 2001-04-23 2004-03-26 Oreal Procede pour augmenter le seuil de tolerance d'une peau sensible ou intolerante
US20030165546A1 (en) * 2002-03-04 2003-09-04 The Procter & Gamble Company Stable personal care compositions containing a retinoid
US6989152B1 (en) 2002-07-08 2006-01-24 John Campbell Compound for the amelioration of pseudofolliculitis
SI1539124T1 (sl) 2002-09-05 2018-12-31 Vanderbilt Royalty Sub L.P. Sestavki in kompleti za odstranjevanje dražilnih spojin s telesnih površin
JP5285201B2 (ja) * 2002-09-25 2013-09-11 株式会社ナノエッグ レチノイン酸ナノカプセル
CN100464741C (zh) * 2002-12-12 2009-03-04 盖尔德马研究及发展公司 含有酚衍生物和类维生素a的含水醇脱色素凝胶
US8008338B2 (en) 2003-06-03 2011-08-30 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
ATE444732T1 (de) 2003-08-07 2009-10-15 Allergan Inc Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
WO2005089317A2 (fr) * 2004-03-15 2005-09-29 3M Innovative Properties Company Formulations modificatrices de reponse immunitaire et procedes correspondants
US20060014834A1 (en) * 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
JP2008519764A (ja) * 2004-11-09 2008-06-12 イマジナティブ リサーチ アソシエィツ インコーポレーテッド レチノイド溶液及びそれからつくった調合物
NZ563560A (en) * 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
US8053000B2 (en) * 2005-06-07 2011-11-08 Dr. Reddy's Laboratories Limited Compositions for drug delivery
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
WO2007092312A2 (fr) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Compositions pour traitement cutane topique
KR101368107B1 (ko) 2006-03-31 2014-03-14 스티펠 리서치 오스트레일리아 피티와이 리미티드 발포성 현탁겔
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
EP2214661A4 (fr) * 2007-10-18 2012-10-03 Medicis Pharmaceutical Corp Rétinoïde aqueux et gel de peroxyde de dibenzoyle
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US20100029765A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Labortories Limited Topical aqueous composition comprising tretinoin
US10123970B2 (en) 2009-05-20 2018-11-13 Sun Pharmaceutical Industries Limited Topical retinoid solutions
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
WO2013019974A1 (fr) 2011-08-02 2013-02-07 Medicis Pharmaceutical Corporation Compositions comprenant un rétinoïde et un antibiotique lincosamide, destinées à être utilisées dans le traitement de la rosacée
KR102151836B1 (ko) * 2013-10-09 2020-09-03 가부시키가이샤 시세이도 저예사성 증점제 및 이 증점제를 배합한 화장료
WO2015063723A1 (fr) 2013-10-31 2015-05-07 Ranbaxy Laboratories Limited Composition pharmaceutique topique d'acitrétine
KR102453888B1 (ko) * 2015-09-30 2022-10-11 (주)아모레퍼시픽 성형이 가능한 모발 케어용 조성물
RU2018119510A (ru) 2015-10-30 2019-12-05 Тимбер Фармасьютикалз ЭлЭлСи Композиции изотретиноина и их применение и способы

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3006939A (en) 1957-01-17 1961-10-31 Basf Ag Production of compounds of the betacyclogeranylidene series
NL257621A (fr) * 1959-11-23
US3592936A (en) * 1969-04-25 1971-07-13 Merck & Co Inc Method of treatment using pharmaceutical composition containing dimethyl sulfoxide
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US3689667A (en) 1970-06-24 1972-09-05 Univ California C22 acid and its salts to promote wound healing
US3882244A (en) 1971-12-13 1975-05-06 Univ California Method of treating acne with a c{hd 20 {b acid
IL41582A0 (en) * 1972-03-03 1973-04-30 Syntex Corp Fatty alcohol-butanediol-glycol solvent cream composition
NL7307072A (fr) * 1972-06-09 1973-12-11
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US4021573A (en) * 1974-04-22 1977-05-03 The Regents Of The University Of California Psoriasis treatment with retinoic acid analogs
DE2843901A1 (de) * 1978-10-07 1980-04-24 Basf Ag Mittel, enthaltend all-e- oder 13-z-7, 8-dehydro-retinsaeure
US4214000A (en) * 1978-10-30 1980-07-22 Johnson & Johnson Zinc salt of all-trans-retinoic acid for the treatment of acne
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
DE3002545A1 (de) 1980-01-25 1981-07-30 Basf Ag, 6700 Ludwigshafen 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
CA1268124A (fr) 1985-06-28 1990-04-24 Werner Bollag Utilisation d'un retinoide
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
US4950475A (en) * 1988-07-19 1990-08-21 Imaginative Research Associates, Inc. Novel film-forming gels with high concentrations of humectants and emollients
MY105521A (en) * 1989-04-17 1994-10-31 Healthpoint Ltd Moisturizing vehicle for topical application of vitamin a acid.
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US20060222712A1 (en) 2005-02-17 2006-10-05 Connetics Corporation Acne gel

Also Published As

Publication number Publication date
US5721275A (en) 1998-02-24
EP0481007A4 (en) 1992-07-22
EP0481007B1 (fr) 1997-01-22
CA2063576C (fr) 1994-01-25
DE69029804D1 (de) 1997-03-06
USRE41134E1 (en) 2010-02-16
DE69029804T2 (de) 1997-09-04
EP0481007A1 (fr) 1992-04-22
WO1990014833A1 (fr) 1990-12-13

Similar Documents

Publication Publication Date Title
CA2063576A1 (fr) Vehicules a liberation lente servant a reduire au minimum l'irritation cutanee due a des compositions topiques
MY112093A (en) Cosmetic delivery system for salicylic acid and process for preparation of the same.
AU2166601A (en) Antiperspirant composition
CA2211006A1 (fr) Composition pharmaceutique d'application topique, son procede de production et son utilisation
HU9503721D0 (en) Stable topical retinoid compositions
CA2286409A1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
HUP9904677A2 (hu) Bőrápoló kozmetikai készítmény
GR3030528T3 (en) Viscoelastic compositions of fluorinated organic compounds
MX9707624A (es) Composiciones desodorantes.
CA2079369A1 (fr) Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition
CA2144845A1 (fr) Compositions germicides detergentes a base d'iode, a teneur reduite en detergent
MX173607B (es) Antitranspirante cristalino y metodo para su preparacion
AU3012901A (en) Antiperspirant composition
CA2406508A1 (fr) Compositions autobronzantes
US4704280A (en) Cosmetic lotion
CA2217767A1 (fr) Composition de traitement pour la peau a ph faible
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
CS275816B6 (en) Cosmetic preparation for use on greasy skin
AU2774292A (en) Toiletries composition
CA2371917A1 (fr) Composition apres-rasage contenant du chlorhydrate d'aluminium
ZA91115B (en) Topical compositions
EP0356264A3 (fr) Composition nettoyante pour la désinfection locale
AU2001244280A1 (en) Silicone oil/cosolvent system concentrated in active liposoluble cosmetic substance(s), corresponding cosmetic emulsion and formulation
ATE285782T1 (de) Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten
IE800344L (en) Anti-perspirant compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed